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The very high incidence of oesophageal squamous cell carcinoma (ESCC) in Golestan Province in northeastern Iran was suggested by
studies in the 1970s as partly due to opium use, which is not uncommon in this area, but based on limited numbers. From December
2003 to June 2007, we administered a validated structured questionnaire to 300 ESCC cases and 571 controls, matched on
neighbourhood of residence, age (±2 years), and sex. We used conditional logistic regression models to calculate odds ratios (ORs)
and 95% confidence intervals (95% CIs) adjusted for potential confounders. Compared with those who used neither tobacco nor
opium, risk of ESCC was increased in those who used tobacco only (OR, 95% CI: 1.70, 1.05–2.73), in those who used opium only
(2.12, 1.21–3.74), and in those who used both tobacco and opium (2.35, 1.50–3.67). All forms of tobacco use (cigarettes, hookah,
and nass) were associated with higher ESCC risk. Similarly, use of both crude opium and other forms of opium were associated with
higher risk. Alcohol consumption was seen in only 2% of the cases and 2% of the controls, and was not associated with ESCC risk.
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Incidence and mortality rates of oesophageal squamous cell
carcinoma (ESCC) in the eastern part of Golestan Province,
northeast Iran, are among the highest in the world (Mahboubi
et al, 1973; Kamangar et al, 2007). Studies conducted by the
International Agency for Research on Cancer (IARC) and Institute
of Public Health Research (IPHR) of the University of Tehran in
the 1970s suggested that opium consumption was one causal factor
(Cook-Mozaffari et al, 1979). Two studies found an almost six-fold
higher prevalence of appreciable levels (X1mgml
 1) of urinary
morphine among residents of the high-risk areas than in lower risk
areas (Joint Iran–IARC Study Group, 1977; Ghadirian et al, 1985).
One of these studies prematurely terminated in 1979, found a two-
fold increased positivity rate for urinary opium metabolites among
spouses of 41 case subjects compared with matched controls
(Ghadirian et al, 1985). Opium use is still prevalent in Golestan
Province, especially among rural men (Pourshams et al, 2004), and
may contribute to the high rates of ESCC in this area.
Heavy alcohol consumption and cigarette smoking are major
causes of ESCC in most parts of the world (Tuyns, 1983; Brown
et al, 1994, 2001), whereas in the 1970s alcohol consumption was
rare in Golestan Province, especially among rural people (Cook-
Mozaffari et al, 1979). These same studies showed that cigarette
smoking, although associated with a two-fold increased risk of
ESCC in Golestan (Cook-Mozaffari et al, 1979), was lower than in
Western countries, where it increases risk by 3–5-fold. Golestan
people may smoke tobacco using a hookah (water pipe) or chew
tobacco as nass, a combination of tobacco, ash, and lime (Joint
Iran–IARC Study Group, 1977; Cook-Mozaffari et al, 1979;
Pourshams et al, 2004), but these have been little studied in
relation to ESCC.
In 2003, we initiated a new case–control study to assess the role
of various risk factors in ESCC in Golestan Province.
MATERIALS AND METHODS
Case and control selection
The study area included the counties of Gonbad, Minoodasht,
Kalaleh, Azadshahr, and Ramian in eastern Golestan province.
Approximately half of the residents of the study area are of
Turkmen ethnicity, and the rest Persians, Kurds, Turks, and
others. Cases were recruited at Atrak Clinic in Gonbad City, the
largest in eastern Golestan Province, and is the only specialised
clinic covering ESCC. Local physicians were asked to refer any
suspected upper gastrointestinal tract cancers to Atrak Clinic. A
local cancer registry showed that approximately 70% of the
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referred to Atrak Clinic (unpublished).
Case subjects were recruited from December 2003 to June 2007,
had histopathologically confirmed ESCC, and agreed to participate
in the study. Other eligibility criteria were being at least 18 years of
age, residing in the study area at the time of registration, and
having no history of concurrent cancer in other organs or history
of previous cancer in any organ. All the patients underwent
oesophago-gastro-duodenal videoendoscopy at Atrak Clinic, and
biopsy samples were sent to the Tehran University Digestive
Disease Research Center (DDRC), in Tehran, where they were
examined by experienced pathologists.
For each case subject, we attempted to select two population-
based control subjects matched to the case for neighbourhood
of residence or village, age (±2 years), and sex. However, for a
minority of cases (B10%), we found only one matched control. In
both rural villages and urban areas, the family health census, which
is conducted annually by the Iranian Public Health Network, was
used to identify eligible controls. In each village, our interview
group identified all of the potentially eligible controls and
randomly selected one to interview. If the first person could not
be interviewed for any reason, the second person on the list was
invited, and so forth. In urban areas, a list of the eligible controls
was ordered by geographic proximity to the case’s residence, with
the list starting from the eligible person living closest to the case’s
residence. If the first person was not available for interview, then
the second closest person was invited, and so forth.
Data collection
The conduct of this study was reviewed and approved by the
Institutional Review Boards of the DDRC, the US National Cancer
Institute (NCI), and IARC. After obtaining written informed
consent from each subject, two trained interviewers, a nurse and a
physician, administered a structured general questionnaire. Also, a
nutritionist administered a validated semiquantitative food
frequency questionnaire that was specifically developed for this
area (Malekshah et al, 2006). During the pilot phase, which
extended from March 2002 to November 2003 (Islami et al, 2004),
interviewers were given a thorough training, questionnaires were
tested for reliability and validity, and databases and other facilities
were improved. To diminish interindividual variation, a limited
number of staff conducted the face-to-face interviews and no
proxies were used. Case subjects were interviewed on the day of
diagnostic upper gastrointestinal endoscopy at the Atrak Clinic.
Rural controls were interviewed in village health houses, urban
controls in urban health centres except those selected from
Gonbad City, who were interviewed at a research facility
established by DDRC for an ongoing cohort study on upper
gastrointestinal tract cancers (Pourshams et al, 2004).
The questionnaire covered lifelong history of tobacco use,
including smoking cigarettes, using hookah (water pipe), and
chewing nass, with starting and stopping ages and daily amount
used. Also, any change in amount and type of tobacco use was
recorded. Ever-cigarette smokers, ever-hookah users, and ever-
nass users were those who had smoked, used, or chewed cigarettes,
hookah, or nass (respectively) at least weekly for a period of 6
months or more. Ever-tobacco users were individuals who had
done any of the above, further classified as current and former
users. Current users were those who had practised any of these
habits within 1 year before the interview. Former users were those
who had stopped their habit at least 1 year prior to the interview.
The general questionnaire covered opium use, which in Golestan
includes teriak (crude opium), shireh (a refined opium extract)
(Hewer et al, 1978), sukhteh (opium dross left in pipes after
smoking opium), and heroin. Teriak and shireh can be smoked or
ingested, sukhteh is usually ingested, and heroin is usually
injected. Opium users, defined as subjects who had consumed
opium at least once per week for a minimum of 6 months, were
asked about type(s) of opiate used, the route of administration, the
age they started and stopped, and the amount consumed. Study
participants were also asked whether they had been given opiates
during infancy or childhood.
Alcohol consumption in the study area is uncommon (Pourshams
et al, 2004). Subjects were asked about type of alcohol used (beer,
imported spirit, country spirit, and others), starting and stopping
ages, and the amount and frequency of use.
Detailed information was also collected on age, sex, education,
ethnicity, place of residence, and other potential confounders.
Responses to questions regarding opium, tobacco, and alcohol
consumption in this area were previously validated (Abnet et al,
2004; Pourshams et al, 2004).
Statistical analysis
For each exposure (opium, cigarette, hookah, nass, and alcohol),
average intensity, total duration, and cumulative use (average
intensity multiplied by duration of use) were categorised into three
groups: no use, low use (pmedian use in controls), and high use
(4median use). Age of first use was similarly categorised.
Percentages were tabulated for each of these categories by case
status. Conditional logistic regression models were used to
calculate unadjusted and adjusted odds ratios (ORs) and 95%
confidence intervals (95% CIs). In all analyses, nonusers were the
referent group. By design, case and control subjects were matched
for age, sex, and place of residence. Results were adjusted for
education (as a marker of socioeconomic status) and ethnicity
(Turkmen vs non-Turkmen). P-values for trend were obtained
from adjusted models by assigning values of 0, 1, and 2 to no use,
low use, and high use, respectively.
We also analysed and present ORs (95% CIs) for different types
of tobacco use and opium use, mutually adjusted for each other,
and for education, ethnicity, and total intake of fruit and
vegetables. Population attributable risks were obtained from these
mutually adjusted models, using the prevalence of tobacco and
opium use in the control subjects. Two-sided P-values p0.05 were
Table 1 Demographic characteristics of ESCC cases and matched
controls
ESCC cases Matched controls
N (%) N (%)
Total 300 (100) 571 (100)
Age (years)
p50 32 (11) 61 (11)
51–60 81 (27) 144 (25)
61–70 86 (29) 177 (31)
470 101 (34) 189 (33)
Gender
Male 150 (50) 278 (49)
Female 150 (50) 293 (51)
Place of residence
Urban 82 (27) 150 (26)
Rural 218 (73) 421 (74)
Ethnicity
Turkmen 171 (57) 312 (55)
Non-Turkmen 129 (43) 259 (45)
ESCC¼oesophageal squamous cell carcinoma. Although cases and controls were
individually matched, the percentages of cases and controls are not necessarily equal
in each age, gender, or place of residence category, because some cases have one
matched control and others have two matched controls.
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done using Stata Software, version 10.0 (StataCorp., College
Station, TX, USA).
RESULTS
Demographic characteristics of the study participants are sum-
marised in Table 1. A total of 300 ESCC case subjects were enrolled
in this study. Of these, 271 had two matched controls and 29 had
one in a total of 571. Mean age (s.d.) was 64.5 (10.1) for cases and
64.3 (10.4) for controls. Of the cases, 50% were male, and 27% lived
in urban areas. Matched for age, sex, and place of residence, 57%
of cases and 55% of controls were of Turkmen ethnicity.
In all, 90 cases (30%) and 106 controls (18%) had ever used
opium (Table 2). Opium use was common in both men and in
women; 32% of men (42% of cases and 27% of controls) and 13%
of women (18% of cases and 11% of controls) had used opium.
Prevalence of ever use increased with age, but was common in all
age groups. Among controls, 11% of those aged p50 years, 19% of
those 51–70 years, and 21% of those 470 years had ever used
opium. Ever use was associated with increased ESCC risk, with an
adjusted OR (95% CI) of 2.00 (1.39–2.88), and for use earlier than
a year prior to diagnosis, was 1.92 (1.30–2.84). Average intensity
of use, duration of use, cumulative use, and age at first use all
showed significant dose–response associations with ESCC risk (all
P-values for trend o0.001). No subject was a sukhteh or heroin
user. Using the teriak or shireh form of opium was associated with
higher risk of ESCC; adjusted ORs (95% CIs) for teriak use only,
shireh use only, or use of both were 1.62 (1.09–2.40), 3.41 (1.35–
8.60), and 8.80 (2.28–33.9), respectively. Both routes of adminis-
tration also increased risk of ESCC; adjusted ORs (95% CIs) for
smoking only, ingestion only, and both were 1.67 (1.06–2.63), 1.90
(1.09–3.32), and 6.61 (2.42–18.0), respectively. Of the 250 cases
and 509 controls who knew whether they were given opium in their
childhood, 23 cases (9%) and 37 controls (7%) stated that they had
received opiates during that time; the adjusted OR (95% CI) was
1.11 (0.61–2.03).
A total of 67 cases (22%) and 99 controls (17%) ever regularly
smoked cigarettes, and this habit was associated with a nearly
significant increased ESCC risk, adjusted OR (95% CI) being 1.47
(0.98–2.21). Risk was higher in current than in former smokers, in
those who smoked above the median intensity among smoking
controls (11 cigarettes per day), for longer than the median
duration among smoking controls (21 years), in those whose
cumulative pack-years was higher than median among smoking
controls (13.5 pack-years), and in those who started smoking
earlier than the median age of starting among controls (25 years);
P-values for trend were significant for all of these comparisons
(Table 3).
Table 2 Opium use in ESCC cases and matched controls
ESCC cases Matched controls Unadjusted Adjusted
N (%) N (%) OR (95% CI) OR (95% CI)
a P for trend
b
Opium use
Never 210 (70) 465 (81) Referent Referent —
Ever 90 (30) 106 (18) 1.95 (1.36–2.78) 2.00 (1.39–2.88)
Average intensity
Never used 210 (70) 465 (81) Referent Referent o0.001
p median (1.5 units per day)
c,d 42 (14) 53 (9) 1.75 (1.11–2.75) 1.72 (1.08–2.72)
4 median 48 (16) 53 (9) 2.19 (1.37–3.51) 2.38 (1.47–3.85)
Duration
Never used 210 (70) 465 (81) Referent Referent o0.001
p median (8.5 years)
d 34 (11) 53 (9) 1.44 (0.88–2.39) 1.47 (0.89–2.44)
4 median 56 (19) 53 (9) 2.37 (1.54–3.65) 2.47 (1.59–3.84)
Cumulative use
e
Never used 210 (70) 465 (81) Referent Referent o0.001
p median (15.5 unit-years)
c,d 41 (14) 53 (9) 1.74 (1.10–2.75) 1.73 (1.09–2.74)
4 median 49 (16) 53 (9) 2.19 (1.38–3.47) 2.34 (1.45–3.78)
Age started
Never used 210 (70) 465 (81) Referent Referent o0.001
4 median 29 (10) 50 (9) 1.26 (0.74–2.16) 1.26 (0.74–2.16)
p median (50 years)
d 61 (20) 56 (10) 2.50 (1.63–3.84) 2.64 (1.71–4.09)
Type of opium used
Never used 210 (70) 465 (81) Referent Referent —
Crude opium (teriak) only 66 (22) 95 (17) 1.56 (1.06–2.31) 1.62 (1.09–2.40)
Refined opium (shireh) only 14 (5) 8 (1) 3.84 (1.57–9.42) 3.41 (1.35–8.60)
Both 10 (3) 3 (1) 7.36 (1.99–27.2) 8.80 (2.28–33.9)
Route of administration
Never used 210 (70) 465 (81) Referent Referent —
Smoked only 45 (15) 62 (11) 1.67 (1.06–2.59) 1.67 (1.06–2.63)
Ingested only 30 (10) 38 (7) 1.86 (1.07–3.21) 1.90 (1.09–3.32)
Both 15 (5) 6 (1) 5.41 (2.05–14.2) 6.61 (2.42–18.0)
95% CI¼95% confidence interval; ESCC¼oesophageal squamous cell carcinoma; OR¼odds ratio. ORs were obtained from conditional logistic regression models.
aAdjusted
for education and ethnicity.
bP for trend was obtained from conditional logistic regression models by assigning values of 0, 1, and 2 to no use, below median, and above median
use, respectively.
cEach unit is one ‘nokhod’, which is approximately equal to 0.2g.
dWe used the median in control subjects as the dividing cut point.
eCumulative use was
calculated by multiplying intensity of use (per day) by duration of use (in years).
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ESCC cases Matched controls Unadjusted Adjusted
N (%) N (%) OR (95% CI) OR (95% CI)
a P for trend
b
Cigarette smoking
c
Never 232 (78) 471 (83) Referent Referent —
Ever 67 (22) 99 (17) 1.35 (0.92–2.00) 1.47 (0.98–2.21)
Cigarette smoking
Never used 232 (78) 471 (83) Referent Referent 0.05
Former smoker 34 (11) 56 (10) 1.24 (0.75–2.03) 1.34 (0.80–2.23)
Current smoker 33 (11) 43 (8) 1.49 (0.90–2.48) 1.63 (0.97–2.76)
Average intensity
Never used 232 (78) 471 (83) Referent Referent 0.01
p median (11 cigarettes per day)
d 22 (7) 49 (9) 0.89 (0.51–1.56) 0.98 (0.55–1.75)
4 median 45 (15) 50 (9) 1.84 (1.13–2.99) 1.98 (1.20–3.25)
Duration
Never used 232 (78) 471 (83) Referent Referent 0.04
p median (21 years)
d 30 (10) 50 (9) 1.18 (0.72–1.94) 1.27 (0.76–2.11)
4 median 37 (12) 49 (9) 1.58 (0.95–2.62) 1.73 (1.03–2.93)
Cumulative use
e
Never used 232 (78) 471 (83) Referent Referent 0.05
p median (13.5 pack-years)
d 31 (10) 50 (9) 1.22 (0.74–2.01) 1.36 (0.81–2.27)
4 median 36 (12) 49 (9) 1.52 (0.91–2.53) 1.61 (0.95–2.74)
Age started
Never used 232 (78) 471 (83) Referent Referent 0.02
4 median 23 (8) 46 (8) 0.98 (0.57–1.68) 1.07 (0.62–1.86)
p median (25 years)
d 44 (15) 53 (9) 1.75 (1.08–2.84) 1.90 (1.15–3.11)
Hookah smoking
Never 280 (93) 548 (96) Referent Referent —
Ever 20 (7) 23 (4) 1.81 (0.95–3.43) 1.85 (0.95–3.58)
Average intensity
Never used 280 (93) 548 (96) Referent Referent 0.03
p median (3 times per day)
d 11 (4) 18 (3) 1.29 (0.59–2.84) 1.31 (0.58–2.96)
4 median 9 (3) 5 (1) 3.51 (1.17–10.5) 3.57 (1.17–11.0)
Duration
Never used 280 (93) 548 (96) Referent Referent 0.21
p median (19 years)
d 15 (5) 12 (2) 2.52 (1.14–5.55) 2.45 (1.09–5.49)
4 median 5 (2) 11 (2) 1.00 (0.34–2.90) 1.11 (0.38–3.30)
Cumulative use
e
Never used 280 (93) 548 (96) Referent Referent 0.11
p median (32 hookah-years)
d 12 (4) 12 (2) 2.07 (0.87–4.88) 2.04 (0.84–4.99)
4 median 8 (3) 11 (2) 1.55 (0.62–3.87) 1.66 (0.65–4.22)
Age started
Never used 280 (93) 548 (96) Referent Referent 0.05
4 median 7 (2) 11 (2) 1.55 (0.62–3.87) 1.38 (0.51–3.69)
p median (40 years)
d 13 (4) 12 (2) 2.22 (0.99–5.00) 2.31 (0.98–5.48)
Nass chewing
Never 256 (85) 523 (92) Referent Referent —
Ever 44 (15) 48 (8) 2.09 (1.28–3.42) 1.99 (1.21–3.28)
Average intensity
Never used 256 (85) 523 (92) Referent Referent 0.004
p median (5.5 times per day)
d 17 (6) 24 (4) 1.59 (0.78–3.25) 1.50 (0.73–3.09)
4 median 27 (9) 24 (4) 2.52 (1.38–4.61) 2.42 (1.31–4.47)
Duration
Never used 256 (85) 523 (92) Referent Referent 0.02
p median (26.5 years)
d 26 (9) 24 (4) 2.44 (1.32–4.49) 2.24 (1.21–4.16)
4 median 18 (6) 24 (4) 1.69 (0.83–3.41) 1.69 (0.83–3.44)
Cumulative use
e
Never used 256 (85) 523 (92) Referent Referent 0.007
p median (150 nass-years)
d 22 (7) 25 (4) 2.19 (1.08–3.73) 1.81 (0.97–3.40)
4 median 22 (7) 23 (4) 2.20 (1.15–4.21) 2.21 (1.15–4.27)
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(Table 3). Ever regularly smoking a hookah was associated with a
nearly significant increased risk of ESCC, with an adjusted OR
(95% CI) of 1.85 (0.95–3.58). Higher average intensity of use (P for
trend¼0.03) and younger age of starting (P for trend¼0.05), but
not duration of use (P for trend¼0.21) or cumulative use (P for
trend¼0.11), showed significant associations with ESCC risk. Of
cases, 44 (15%) and 48 controls (8%) had ever chewed nass. Ever
regularly chewing nass showed increased ESCC risk, with an
adjusted OR (95% CI) of 1.99 (1.21–3.28). Average intensity of use
(P for trend¼0.004), duration of use (P for trend¼0.02),
cumulative use (P for trend¼0.007), and age of first use (P for
trend¼0.01), all showed significant associations with risk
(Table 3).
Adjusted ORs (95% CIs) for cigarette use alone, hookah use
alone, nass chewing alone, and combinations of two or more types
were 1.50 (0.92–2.43), 1.69 (0.76–3.77), 2.91 (1.46–5.77), and 2.11
(1.15–3.86), respectively (Table 4). Compared with using neither
(Table 4), tobacco use alone, opium use alone, and a combination
of the two were all significantly associated with higher ESCC risk,
with adjusted ORs (95% CIs) of 1.70 (1.05–2.73), 2.12 (1.21–3.74),
and 2.35 (1.50–3.67), respectively. Using results from Table 4,
tobacco and opium use accounted for 30% of the cases in this
study.
Only 21 subjects, 7 cases (2%) and 14 controls (2%), had ever
used alcohol for 6 months or more, adjusted OR (95% CI) 0.93
(0.37–2.34). There was no significant association between
intensity, duration, cumulative use, or age of first use of alcohol
with ESCC risk (data not shown).
DISCUSSION
Our study showed that opium consumption, tobacco smoking, and
chewing, but not alcohol consumption, are associated with higher risk
of ESCC in Golestan Province. The area is well-placed to study the
relationship between opium use and ESCC, both of which are
common. A large proportion of the world’s opium is produced in
Afghanistan, which borders Iran, and it is still commonly used in this
region as a traditional treatment of pain, diarrhoea, and insomnia. An
ecologic study in northern Iran found that 50% (20 out of 40) of
adults in ESCC high-risk areas, compared with only 11% (10 out of
90) of those in medium- or low-risk areas, tested positive for urine
morphine metabolites (Joint Iran–IARC Study Group, 1977). In a
subsequent study of 1590 rural individuals, the prevalence of
appreciable levels (X1mgml
 1) of urinary morphine metabolites
was almost six-fold higher among residents of high-risk vs low-risk
areas (Ghadirian et al, 1985). Among the spouses of 41 cases and 41
age-matched controls, there was a two-fold, nonsignificant, increased
risk associated with the presence of urinary morphine metabolites.
Previous studies in Iran (Cook-Mozaffari et al, 1979; Ghadirian
et al, 1985) avoided using questionnaires to ask about opium use,
partly because it can be a sensitive subject in many populations,
which may limit the validity of questionnaire responses. This was
tested during the pilot phase of an ongoing cohort study
in Golestan by interviewing subjects twice and collecting urine
samples twice, 2 months apart (Abnet et al, 2004). Overall
agreement between the responses in the two interviews for ever
using opium was excellent and above 0.99, the corresponding
k-statistic being 0.96 (Abnet et al, 2004). The validity of self-
Table 3 (Continued)
ESCC cases Matched controls Unadjusted Adjusted
N (%) N (%) OR (95% CI) OR (95% CI)
a P for trend
b
Age started
Never used 256 (85) 523 (92) Referent Referent 0.01
4 median 25 (8) 27 (5) 2.07 (1.06–4.04) 1.91 (0.98–3.75)
p median (40 years)
d 19 (6) 21 (4) 2.11 (1.13–3.94) 2.06 (1.09–3.89)
95% CI¼95% confidence interval; ESCC¼oesophageal squamous cell carcinoma; OR¼odds ratio. ORs were obtained from conditional logistic regression models.
bAdjusted
for education and ethnicity.
aP for trend was obtained from conditional logistic regression models by assigning values of 0, 1, and 2 to no use, below median, and above median
use, respectively.
cCigarette smoking status was unknown for one case and one control. Therefore, the total number of subjects in the cigarette smoking analysis is 299 cases and
570 controls.
dWe used the median in control subjects as the dividing cut point.
eCumulative use was calculated by multiplying intensity of use (per day) by duration of use (in
years).
Table 4 The association between tobacco types and between tobacco and opium use, alone or in combination, and ESCC
ESCC cases Matched controls Unadjusted Adjusted
N (%) N (%) OR (95% CI) OR (95% CI)
a
Tobacco type used
Never used 196 (66) 432 (76) Referent Referent
Cigarettes only 41 (14) 68 (12) 1.32 (0.83–2.11) 1.50 (0.92–2.43)
Hookah only 12 (4) 18 (3) 1.66 (0.75–3.67) 1.69 (0.76–3.77)
Nass only 23 (8) 20 (4) 3.03 (1.53–5.96) 2.91 (1.46–5.77)
More than one type 27 (9) 32 (6) 2.12 (1.18–3.83) 2.11 (1.15–3.86)
Used neither tobacco nor opium 166 (56) 398 (70) Referent Referent
Used tobacco but not opium 43 (14) 66 (12) 1.68 (1.05–2.68) 1.70 (1.05–2.73)
Used opium but not tobacco 30 (10) 34 (6) 2.22 (1.27–3.87) 2.12 (1.21–3.74)
Used both tobacco and opium 60 (20) 72 (13) 2.20 (1.42–3.40) 2.35 (1.50–3.67)
95% CI¼95% confidence interval; ESCC¼oesophageal squamous cell carcinoma; OR¼odds ratio. ORs were obtained from conditional logistic regression models.
aAdjusted
for education, ethnicity, and total intake of fruit and vegetables.
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codeine or morphine in the urine, self-report had a sensitivity of
0.93 and specificity of 0.89 (Abnet et al, 2004), so we accepted
questionnaire to document opium use. The results of our study
showed a two-fold increased risk of ESCC associated with opium
use. People in Golestan may start using opiates to alleviate pain
prior to their cancer diagnosis and, therefore, reverse causality is a
concern. However, excluding the cases and controls who had
recently started using opium from the analysis made no material
difference in the study results, and younger age at first use was a
strong predictor of cancer risk. Limiting the analysis to tobacco
nonusers, the results remained essentially unchanged. The
percentage of opium users in ESCC case subjects (30%) found in
this study is close to the percentage (33%) found in the pilot phase
study (Islami et al, 2004).
The two forms of opium used by the subjects of this study were
teriak (crude opium) and shireh (refined opium). Shireh is usually
made by boiling teriak (or a mixture of teriak and opium pyrolysates
obtained after smoking opium) with water, filtering the mixture
several times, and, then, evaporating the filtrate until a gummy
consistency is achieved. Both teriak and shireh can be smoked or
ingested. We found that consumption of both teriak and shireh are
common, and both are associated with increased risk of ESCC, also
both, smoking and ingesting, alone or in combination.
Neither teriak nor shireh themselves were mutagenic in the
Ames test (Hewer et al, 1978). However, either smoking or inhaling
the smoke involves exposure to potential carcinogens, including
polycyclic aromatic hydrocarbons (PAHs) to which industrial
exposure may cause cancers of the lung, bladder, and skin
(Denissenko et al, 1996; Boffetta et al, 1997; Hecht, 2003). Smoke
condensates from opium and morphine cause mutations in
Salmonella typhimurium (Hewer et al, 1978; Malaveille et al,
1982), sister chromatid exchanges in human lymphocytes (Perry
et al, 1983), and morphological transformations in cultured Syrian
hamster embryo cells (Friesen et al, 1985), whereas crude opium
itself is not a mutagen (Hewer et al, 1978; Malaveille et al, 1982).
The mechanisms responsible for the carcinogenic effects of opium
and shireh need investigation.
In Western countries, cigarette smoking increases ESCC risk by
approximately 3–5-fold (Tuyns, 1983; Brown et al, 1994, 2001).
However, in some high-risk areas, such as Linxian (China),
smoking plays a much less significant role in the aetiology of
ESCC, and the relative risk for ever-cigarette smoking is only 1.3
(Tran et al, 2005). The case–control study conducted by IARC and
IPHR in the 1970s in Golestan Province showed an almost two-fold
risk of ESCC associated with tobacco smoking (Cook-Mozaffari
et al, 1979) and adjusted OR of 1.47 confirms a weak-to-moderate
association in Golestan. Discordance between smoking prevalence
and ESCC rates in women and men in these high risk areas, is in
agreement with the finding of smoking is not a strong risk factor in
these population. In Linxian, o1% of women and approximately
70% of men smoke (Abnet et al, 2001), yet ESCC rates are nearly
equal in the two sexes as in Golestan, where the prevalence of ever
smoking ranges from 1% in rural women to 39% in urban men
(Pourshams et al, 2004), suggesting that most ESCC cases in
Linxian and Golestan are due to other factors. This relatively weak
association between smoking and ESCC risk may also be due in
part to the relatively low cumulative tobacco exposure; median
cumulative use among smoking controls in this study was only
13.5 pack-years.
The association of ESCC with smoking hookah or chewing nass
has been little studied. In our study, although the CIs are wide, the
point estimates suggest that these are at least as strong risk factors
as cigarette smoking. Regular use of hookah may involve exposure
to large amounts of tobacco combustion products. Because nass is
a mixture of tobacco, ash, and lime (Joint Iran–IARC Study
Group, 1977; Cook-Mozaffari et al, 1979; Pourshams et al, 2004), it
exposes users to carcinogens both in unburned tobacco (e.g.,
nitrosamines, PAHs, and aldehydes) and in ash (e.g., PAHs). In
our study, both the intensity of hookah use and the intensity and
duration of nass use showed positive trends with ESCC risk, but
not duration of hookah use, perhaps partly due to people changing
from hookah to cigarettes. Consistent with our findings, snus
(Scandinavian moist snuff) use is associated with a three-fold
significant increased risk of ESCC (Zendehdel et al, 2008).
However, there was no association between hookah or nass use
and ESCC risk in the previous IARC–IPHR case–control study
(Cook-Mozaffari et al, 1979).
Like tobacco smoking, alcohol use is a major cause of ESCC in
Western countries (Jensen, 1979; Tuyns, 1983; Boffetta and
Garfinkel, 1990; Brown et al, 1994, 2001), but not in Linxian (Tran
et al, 2005), or Iran (Joint Iran–IARC Study Group, 1977;
Pourshams et al, 2004), where consumption is very limited. In
the West, alcohol intake is associated with a dose–response
increase in ESCC risk, and heavy consumption increases risk by
5–15-fold (Tuyns, 1983; Boffetta and Garfinkel, 1990; Brown et al,
1994; Baan et al, 2007). In our study, approximately 2% of cases
and 2% of controls had ever regularly used alcohol, which was not
significantly associated with ESCC risk.
Overall agreement between responses to each of the cigarette,
nass, and alcohol questions in the two interviews was above
0.99, and the corresponding k-statistics were all above 0.95 (Abnet
et al, 2004), showing excellent reliability.
Although the ESCC incidence rate is still high in Golestan
Province, it has declined in the past few decades, particularly
among younger people (Semnani et al, 2006). Factors contributing
to this decline may include improved socioeconomic status, more
widespread access to piped water, and more fresh fruits and
vegetable use due to greater availability of refrigerators. Also, the
prevalence of opium use in our study was approximately half of
that reported in the 1970s (Ghadirian et al, 1985), when sukhteh
use was common (Hewer et al, 1978), but not reported by our
subjects.
The strengths of this study include the relatively large sample
size, strict matching for area of residence to avoid possibility of
confounding by region, verification of the reliability and validity of
questionnaires, histologic confirmation of all case diagnoses, and
appropriate sensitivity analyses. Limitations include recall bias,
but as most subjects were illiterate or with little education, and
were unaware of the study hypotheses, it is unlikely that reported
opium, tobacco, or alcohol use are differentially higher in case
than in control subjects.
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